BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 17084548)

  • 1. Dosimetric and toxicity comparison between prone and supine position IMRT for endometrial cancer.
    Beriwal S; Jain SK; Heron DE; de Andrade RS; Lin CJ; Kim H
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):485-9. PubMed ID: 17084548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcome of adjuvant treatment of endometrial cancer using aperture-based intensity-modulated radiotherapy.
    Bouchard M; Nadeau S; Gingras L; Raymond PE; Beaulieu F; Beaulieu L; Fortin A; Germain I
    Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1343-50. PubMed ID: 18294780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized trial of supine vs. prone positioning in patients undergoing escalated dose conformal radiotherapy for prostate cancer.
    Bayley AJ; Catton CN; Haycocks T; Kelly V; Alasti H; Bristow R; Catton P; Crook J; Gospodarowicz MK; McLean M; Milosevic M; Warde P
    Radiother Oncol; 2004 Jan; 70(1):37-44. PubMed ID: 15036850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase II trial for the optimisation of treatment position in the radiation therapy of prostate cancer.
    O'Neill L; Armstrong J; Buckney S; Assiri M; Cannon M; Holmberg O
    Radiother Oncol; 2008 Jul; 88(1):61-6. PubMed ID: 18453021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensity-modulated radiotherapy improves lymph node coverage and dose to critical structures compared with three-dimensional conformal radiation therapy in clinically localized prostate cancer.
    Wang-Chesebro A; Xia P; Coleman J; Akazawa C; Roach M
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):654-62. PubMed ID: 17011444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The normal tissue sparing obtained with simultaneous treatment of pelvic lymph nodes and bladder using intensity-modulated radiotherapy.
    Søndergaard J; Høyer M; Petersen JB; Wright P; Grau C; Muren LP
    Acta Oncol; 2009; 48(2):238-44. PubMed ID: 18759144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of intensity-modulated radiotherapy in reducing toxicity in dose escalation for localized prostate cancer.
    Al-Mamgani A; Heemsbergen WD; Peeters ST; Lebesque JV
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):685-91. PubMed ID: 18718725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A dosimetric analysis of intensity-modulated radiation therapy (IMRT) as an alternative to adjuvant high-dose-rate (HDR) brachytherapy in early endometrial cancer patients.
    Aydogan B; Mundt AJ; Smith BD; Mell LK; Wang S; Sutton H; Roeske JC
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):266-73. PubMed ID: 16618581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetric comparison of bone marrow-sparing intensity-modulated radiotherapy versus conventional techniques for treatment of cervical cancer.
    Mell LK; Tiryaki H; Ahn KH; Mundt AJ; Roeske JC; Aydogan B
    Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1504-10. PubMed ID: 18640499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute toxicity in definitive versus postprostatectomy image-guided radiotherapy for prostate cancer.
    Cheng JC; Schultheiss TE; Nguyen KH; Wong JY
    Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):351-7. PubMed ID: 18164841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment with a belly-board device significantly reduces the volume of small bowel irradiated and results in low acute toxicity in adjuvant radiotherapy for gynecologic cancer: results of a prospective study.
    Martin J; Fitzpatrick K; Horan G; McCloy R; Buckney S; O'Neill L; Faul C
    Radiother Oncol; 2005 Mar; 74(3):267-74. PubMed ID: 15763307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetric comparison of combined intensity-modulated radiotherapy (IMRT) and proton therapy versus IMRT alone for pelvic and para-aortic radiotherapy in gynecologic malignancies.
    Milby AB; Both S; Ingram M; Lin LL
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e477-84. PubMed ID: 22177626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcome with adjuvant treatment of endometrial carcinoma using intensity-modulated radiation therapy.
    Beriwal S; Jain SK; Heron DE; Kim H; Gerszten K; Edwards RP; Kelley JL
    Gynecol Oncol; 2006 Aug; 102(2):195-9. PubMed ID: 16647748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer.
    Zelefsky MJ; Levin EJ; Hunt M; Yamada Y; Shippy AM; Jackson A; Amols HI
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1124-9. PubMed ID: 18313526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypofractionated whole-breast radiation therapy: does breast size matter?
    Hannan R; Thompson RF; Chen Y; Bernstein K; Kabarriti R; Skinner W; Chen CC; Landau E; Miller E; Spierer M; Hong L; Kalnicki S
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):894-901. PubMed ID: 22543209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors influencing bowel sparing in intensity modulated whole pelvic radiotherapy for gynaecological malignancies.
    Georg P; Georg D; Hillbrand M; Kirisits C; Pötter R
    Radiother Oncol; 2006 Jul; 80(1):19-26. PubMed ID: 16766068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensity-modulated radiotherapy for the treatment of vulvar carcinoma: a comparative dosimetric study with early clinical outcome.
    Beriwal S; Heron DE; Kim H; King G; Shogan J; Bahri S; Gerszten K; Lee J; Kelley J; Edwards RP
    Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1395-400. PubMed ID: 16442238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duodenal and other gastrointestinal toxicity in cervical and endometrial cancer treated with extended-field intensity modulated radiation therapy to paraaortic lymph nodes.
    Poorvu PD; Sadow CA; Townamchai K; Damato AL; Viswanathan AN
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1262-8. PubMed ID: 23182395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late radiotherapy-induced lower intestinal toxicity (RILIT) of intensity-modulated radiotherapy for prostate cancer: the need for adapting toxicity scales and the appearance of the sigmoid colon as co-responsible organ for lower intestinal toxicity.
    Fonteyne V; De Neve W; Villeirs G; De Wagter C; De Meerleer G
    Radiother Oncol; 2007 Aug; 84(2):156-63. PubMed ID: 17692976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosimetric effects of the prone and supine positions on image guided localized prostate cancer radiotherapy.
    Liu B; Lerma FA; Patel S; Amin P; Feng Y; Yi BY; Yu C
    Radiother Oncol; 2008 Jul; 88(1):67-76. PubMed ID: 18207595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.